| 000 | 01350 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515012201.0 | ||
| 264 | 0 | _c20060126 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1262-3636 | ||
| 024 | 7 |
_a10.1016/s1262-3636(05)88265-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aValensi, P | |
| 245 | 0 | 0 |
_aIs insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects? _h[electronic resource] |
| 260 |
_bDiabetes & metabolism _cSep 2005 |
||
| 300 |
_a4S34-4S39 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 | _aCircadian Rhythm |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aInsulin _xanalogs & derivatives |
| 650 | 0 | 4 | _aInsulin Detemir |
| 650 | 0 | 4 | _aInsulin Glargine |
| 650 | 0 | 4 |
_aInsulin, Isophane _xpharmacokinetics |
| 650 | 0 | 4 | _aInsulin, Long-Acting |
| 650 | 0 | 4 | _aReproducibility of Results |
| 700 | 1 | _aCosson, E | |
| 773 | 0 |
_tDiabetes & metabolism _gvol. 31 _gno. 4 Pt 2 _gp. 4S34-4S39 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1262-3636(05)88265-5 _zAvailable from publisher's website |
| 999 |
_c16007944 _d16007944 |
||